Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nancy Monroy-Jaramillo

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
Archives of Medical Research|April 3, 2022
Impact of COMT, PRODH and DISC1 Genetic Variants on Cognitive Performance of Patients with SchizophreniaIngrid Fricke-Galindo, Blanca E Pérez-Aldana, Luis R Macías-Kauffer, et al.
Boletin Medico Del Hospital Infantil De Mexico|July 28, 2020
X-linked hypohidrotic ectodermal dysplasia by a de novo recurrent variant in a Mexican patientMiguel A Noriega-Juárez, Constanza García-Delgado, América Villaseñor-Domínguez, et al.
Parkinsonism & Related Disorders|September 14, 2020
First report of pathogenic SGCE variants in Mexican patients with myoclonus dystonia: A five-year follow-up studyDavid J Dávila-Ortiz de Montellano, María de Lourdes González-Del Rincón, Nancy Monroy-Jaramillo, et al.
Molecular Neuropsychiatry|April 26, 2019
Brain Gene Expression Pattern of Subjects with Completed Suicide and Comorbid Substance Use DisorderBrenda Cabrera, Nancy Monroy-Jaramillo, Gabriel Rodrigo Fries, et al.
Revista De Investigacion Clinica; Organo Del Hospital De Enfermedades De La Nutricion|June 4, 2020
Brain Gene Expression-DNA Methylation Correlation in Suicide Completers: Preliminary ResultsBrenda Cabrera-Mendoza, José J Martínez-Magaña, Alma D Genis-Mendoza, et al.
Journal of the Neurological Sciences|March 6, 2016
Synaptotagmin XI in Parkinson's disease: New evidence from an association study in Spain and MexicoAngel Sesar, Pilar Cacheiro, Marisol López-López, et al.
Pharmaceuticals (Basel, Switzerland)|February 9, 2021
Integrative Genomic-Epigenomic Analysis of Clozapine-Treated Patients with Refractory PsychosisYerye Gibrán Mayén-Lobo, José Jaime Martínez-Magaña, Blanca Estela Pérez-Aldana, et al.
Revista Brasileira De Psiquiatria (Sao Paulo, Brazil : 1999)|November 1, 2022
Influence of glutathione-related genetic variants on the oxidative stress profile of Mexican patients with psychotic disordersYerye G Mayén-Lobo, Mireya Alcaraz-Zubeldia, David J Dávila-Ortiz de Montellano, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|January 6, 2021
Candidate pharmacological treatments for substance use disorder and suicide identified by gene co-expression network-based drug repositioningBrenda Cabrera-Mendoza, José Jaime Martínez-Magaña, Nancy Monroy-Jaramillo, et al.
Journal of Affective Disorders|February 18, 2020
Sex differences in brain gene expression among suicide completersBrenda Cabrera-Mendoza, Cristóbal Fresno, Nancy Monroy-Jaramillo, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Archives of Medical Research|April 3, 2022
Impact of COMT, PRODH and DISC1 Genetic Variants on Cognitive Performance of Patients with SchizophreniaIngrid Fricke-Galindo, Blanca E Pérez-Aldana, Luis R Macías-Kauffer, et al.
Boletin Medico Del Hospital Infantil De Mexico|July 28, 2020
X-linked hypohidrotic ectodermal dysplasia by a de novo recurrent variant in a Mexican patientMiguel A Noriega-Juárez, Constanza García-Delgado, América Villaseñor-Domínguez, et al.
Parkinsonism & Related Disorders|September 14, 2020
First report of pathogenic SGCE variants in Mexican patients with myoclonus dystonia: A five-year follow-up studyDavid J Dávila-Ortiz de Montellano, María de Lourdes González-Del Rincón, Nancy Monroy-Jaramillo, et al.
Molecular Neuropsychiatry|April 26, 2019
Brain Gene Expression Pattern of Subjects with Completed Suicide and Comorbid Substance Use DisorderBrenda Cabrera, Nancy Monroy-Jaramillo, Gabriel Rodrigo Fries, et al.
Revista De Investigacion Clinica; Organo Del Hospital De Enfermedades De La Nutricion|June 4, 2020
Brain Gene Expression-DNA Methylation Correlation in Suicide Completers: Preliminary ResultsBrenda Cabrera-Mendoza, José J Martínez-Magaña, Alma D Genis-Mendoza, et al.
Journal of the Neurological Sciences|March 6, 2016
Synaptotagmin XI in Parkinson's disease: New evidence from an association study in Spain and MexicoAngel Sesar, Pilar Cacheiro, Marisol López-López, et al.
Pharmaceuticals (Basel, Switzerland)|February 9, 2021
Integrative Genomic-Epigenomic Analysis of Clozapine-Treated Patients with Refractory PsychosisYerye Gibrán Mayén-Lobo, José Jaime Martínez-Magaña, Blanca Estela Pérez-Aldana, et al.
Revista Brasileira De Psiquiatria (Sao Paulo, Brazil : 1999)|November 1, 2022
Influence of glutathione-related genetic variants on the oxidative stress profile of Mexican patients with psychotic disordersYerye G Mayén-Lobo, Mireya Alcaraz-Zubeldia, David J Dávila-Ortiz de Montellano, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|January 6, 2021
Candidate pharmacological treatments for substance use disorder and suicide identified by gene co-expression network-based drug repositioningBrenda Cabrera-Mendoza, José Jaime Martínez-Magaña, Nancy Monroy-Jaramillo, et al.
Journal of Affective Disorders|February 18, 2020
Sex differences in brain gene expression among suicide completersBrenda Cabrera-Mendoza, Cristóbal Fresno, Nancy Monroy-Jaramillo, et al.
Pageof 5